To include your compound in the COVID-19 Resource Center, submit it here.

Homology, Unum planning IPOs

Gene therapy and gene editing company Homology Medicines Inc. (Bedford, Mass.) and immuno-oncology company Unum Therapeutics Inc. (Cambridge, Mass.) each filed for IPOs on NASDAQ.

Homology hopes to raise up to $100 million in an offering underwritten

Read the full 365 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers